Transcatheter arterial chemoembolization or transarterial chemoembolization (TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumor’s blood supply. Small embolic particles coated with chemotherapeutic drugs are injected selectively through a catheter into an artery directly supplying the tumor. These particles both block the blood supply and induce cytotoxicity, attacking the tumor in several ways. Transarterial chemoembolization is also increasingly being used for patients on the transplant waiting list to prevent tumor growth.
The global transcatheter arterial chemoembolization (TACE) market provides market size (revenue US$ million) and number of procedures for TACE, market size (revenue US$ million) and volume (number of units) for micro catheter, micro guidewire used in TACE procedures, growth trends and forecast (CAGR%, 2017 to 2021). The global transcatheter arterial chemoembolization market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, South Korea, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global transcatheter arterial chemoembolization market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis.
The TACE market has been estimated based on HCC prevalence and incidence in each country/region using the Barcelona Clinic Liver cancer (BCLC) staging system and treatment strategy and Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma, proposed by the Japan Society of Hepatology (JSH), 2012.
The global report tracks the major competitors operating in the market by market share analysis by key players, company overview, financial snapshot, key products, technologies and services offered. Major players operating in the global embolization in interventional oncology market and included in this report are Abbott Laboratories, Inc. (St. Jude Medical), ABK Biomedical, Inc., Asahi Intecc Co., Ltd., BioSphere Medical, Inc. (Merit Medical Systems, Inc.), Blockade Medical, (BALT International), Boston Scientific Corporation, Braile Biomedica, BTG International, Cook Medical, Inc., Covidien plc (Medtronic plc), Depuy Synthes (JnJ), Guerbet Group, Magle Life Science, Medtronic, Inc. (Covidien), Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., PharmaCept, Piolax Medical Devices, Inc. (Piolax, Inc.), Sequent Medical (Terumo Corporation), Sirtex Medical Limited, Inc., Stryker Corporation, Surefire Medical, Inc., Terumo Medical Corporation, and Vascular Solutions, Inc..